Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

USA - NASDAQ:DNUT - US50101L1061 - Common Stock

3.62 USD
+0.19 (+5.54%)
Last: 9/29/2025, 2:43:04 PM
Fundamental Rating

1

Taking everything into account, DNUT scores 1 out of 10 in our fundamental rating. DNUT was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. DNUT may be in some trouble as it scores bad on both profitability and health. DNUT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DNUT has reported negative net income.
In the past year DNUT has reported a negative cash flow from operations.
DNUT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years DNUT had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

DNUT has a worse Return On Assets (-17.16%) than 88.89% of its industry peers.
With a Return On Equity value of -65.09%, DNUT is not doing good in the industry: 65.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.16%
ROE -65.09%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT has a Gross Margin of 29.14%. This is in the lower half of the industry: DNUT underperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

0

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DNUT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DNUT has more shares outstanding
Compared to 1 year ago, DNUT has a worse debt to assets ratio.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DNUT has an Altman-Z score of 0.12. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.12, DNUT is doing worse than 82.22% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that DNUT has dependencies on debt financing.
DNUT has a Debt to Equity ratio (1.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 0.12
ROIC/WACCN/A
WACC8.17%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

DNUT has a Current Ratio of 0.34. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.34, DNUT is not doing good in the industry: 85.93% of the companies in the same industry are doing better.
DNUT has a Quick Ratio of 0.34. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.26, DNUT is not doing good in the industry: 88.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.26
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The earnings per share for DNUT have decreased strongly by -183.33% in the last year.
Looking at the last year, DNUT shows a very negative growth in Revenue. The Revenue has decreased by -11.55% in the last year.
DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-13.46%

3.2 Future

The Earnings Per Share is expected to decrease by -29.84% on average over the next years. This is quite bad
Based on estimates for the next years, DNUT will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-304%
EPS Next 2Y-73.95%
EPS Next 3Y-29.97%
EPS Next 5Y-29.84%
Revenue Next Year-8.72%
Revenue Next 2Y-4.12%
Revenue Next 3Y-0.41%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DNUT. In the last year negative earnings were reported.
Also next year DNUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than the industry average as 74.81% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.88
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as DNUT's earnings are expected to decrease with -29.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.95%
EPS Next 3Y-29.97%

5

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 4.23%, which is a nice return.
Compared to an average industry Dividend Yield of 6.83, DNUT pays a better dividend. On top of this DNUT pays more dividend than 90.37% of the companies listed in the same industry.
DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.23%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-5.28%
EPS Next 2Y-73.95%
EPS Next 3Y-29.97%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

KRISPY KREME INC

NASDAQ:DNUT (9/29/2025, 2:43:04 PM)

3.62

+0.19 (+5.54%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners43.46%
Inst Owner Change-11.58%
Ins Owners3.6%
Ins Owner Change1.74%
Market Cap619.74M
Analysts54.67
Price Target4.52 (24.86%)
Short Float %27.79%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield 4.23%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-5.28%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-177.39%
Min EPS beat(2)-353.46%
Max EPS beat(2)-1.32%
EPS beat(4)0
Avg EPS beat(4)-159.22%
Min EPS beat(4)-353.46%
Max EPS beat(4)-1.32%
EPS beat(8)1
Avg EPS beat(8)-88.63%
EPS beat(12)4
Avg EPS beat(12)-59.14%
EPS beat(16)5
Avg EPS beat(16)-45.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.92%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.14%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-2.08%
Revenue beat(12)4
Avg Revenue beat(12)-1.18%
Revenue beat(16)4
Avg Revenue beat(16)-1.25%
PT rev (1m)-15.94%
PT rev (3m)-37.9%
EPS NQ rev (1m)11.29%
EPS NQ rev (3m)-24.36%
EPS NY rev (1m)3.03%
EPS NY rev (3m)-164.23%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.64%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB N/A
EV/EBITDA 27.88
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS8.99
BVpS4.05
TBVpS-4.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.16%
ROE -65.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.14%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score3
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 16.28
Cap/Depr 84.51%
Cap/Sales 7.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.26
Altman-Z 0.12
F-Score3
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y-304%
EPS Next 2Y-73.95%
EPS Next 3Y-29.97%
EPS Next 5Y-29.84%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-13.46%
Revenue Next Year-8.72%
Revenue Next 2Y-4.12%
Revenue Next 3Y-0.41%
Revenue Next 5Y3.86%
EBIT growth 1Y-745.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year439.69%
EBIT Next 3Y92.02%
EBIT Next 5YN/A
FCF growth 1Y-875.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.45%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%